Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Leila Gobejishvili, Walter E Rodriguez, Philip Bauer, Yali Wang, Chirag Soni, Todd Lydic, Shirish Barve, Craig McClain & Claudio Maldonado. (2022) Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis. Drug Design, Development and Therapy 16, pages 1301-1309.
Read now
Read now
Takatoshi Hikida, Nao J Gamo & Akira Sawa. (2012) DISC1 as a therapeutic target for mental illnesses. Expert Opinion on Therapeutic Targets 16:12, pages 1151-1160.
Read now
Read now
Kouya Yamaki, Xiaojuan Li, Md. Aslam Hossain, A. H. M. Khurshid Alam, Shinji Taneda, Rie Yanagisawa, Hirohisa Takano & Shin Yoshino. (2007) Difference in Preventive Effects Between the Phosphodiesterase IV Inhibitor Rolipram and Anti-Arthritic Drugs on Antigen-Induced Arthritis in Mice. Immunological Investigations 36:2, pages 131-145.
Read now
Read now
W. Krause & G. Kühne. (1993) Biotransformation of the antidepressant D,L-rolipram. II. Metabolite patterns in man, rat, rabbit, rhesus and cynomolgus monkey. Xenobiotica 23:11, pages 1277-1288.
Read now
Read now
W. Krause, G. Kühne & H. Matthes. (1989) Pharmacokinetics of the Antidepressant Rolipram in Healthy Volunteers. Xenobiotica 19:6, pages 683-692.
Read now
Read now
Articles from other publishers (76)
Max B. Butler, Sundar K. Vellaiyappan, Faheem Bhatti, Fazal-E-Momin Syed, Amir Rafati Fard, Jye Quan Teh, Ben Grodzinski, Melika Akhbari, Sylva Adeeko, Rory Dilworth, Aniqah Bhatti, Unaiza Waheed, Sophie Robinson, Temidayo Osunronbi, Benn Walker, Luke Ottewell, Gayathri Suresh, Isla Kuhn, Benjamin M. Davies, Mark R. N. Kotter & Oliver D. Mowforth. (2023) The impact of phosphodiesterase inhibition on neurobehavioral outcomes in preclinical models of traumatic and non-traumatic spinal cord injury: a systematic review. Frontiers in Medicine 10.
Crossref
Crossref
Artur Świerczek, Bartosz Pomierny, Elżbieta Wyska & William J. Jusko. (2022) Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis. Journal of Pharmacology and Experimental Therapeutics 381:2, pages 151-163.
Crossref
Crossref
Mayasah Y. Al-Nema & Anand Gaurav. (2020) Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia. Current Topics in Medicinal Chemistry 20:26, pages 2404-2421.
Crossref
Crossref
Artur Świerczek, Krzysztof Pociecha, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Sebastian Baś, Jacek Mlynarski, Krzysztof Więckowski, Monika Zadrożna, Barbara Nowak & Elżbieta Wyska. (2020) Comparative Assessment of the New PDE7 Inhibitor – GRMS-55 and Lisofylline in Animal Models of Immune-Related Disorders: A PK/PD Modeling Approach. Pharmaceutical Research 37:2.
Crossref
Crossref
Sara Ramezani, Nasim Vousooghi, Fatemeh Ramezani Kapourchali, Shahrokh Yousefzadeh-Chabok, Zoheir Reihanian, Ali Mohammad Alizadeh, Saeed Khodayari & Hamid Khodayari. (2019) Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model. Life Sciences 239, pages 116880.
Crossref
Crossref
Yinuo Wu, Zhe Li, Yi-You Huang, Deyan Wu & Hai-Bin Luo. (2018) Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease. Journal of Medicinal Chemistry 61:13, pages 5467-5483.
Crossref
Crossref
P.R.A. Heckman, A. Blokland, E.P.P. Bollen & J. Prickaerts. (2018) Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations. Neuroscience & Biobehavioral Reviews 87, pages 233-254.
Crossref
Crossref
Yucong Peng, Jianxiang Jin, Linfeng Fan, Hangzhe Xu, Pingyou He, Jianru Li, Ting Chen, Wu Ruan & Gao Chen. (2018) Rolipram Attenuates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats: Possibly via Regulating the SIRT1/NF-κB Pathway. Neurochemical Research 43:4, pages 785-795.
Crossref
Crossref
Qun Li, Yucong Peng, Linfeng Fan, Hangzhe Xu, Pingyou He, Shenglong Cao, Jianru Li, Ting Chen, Wu Ruan & Gao Chen. (2018) Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway. Biomedicine & Pharmacotherapy 99, pages 947-955.
Crossref
Crossref
P. R. A. Heckman, J. V. Schweimer, T. Sharp, J. Prickaerts & A. Blokland. (2017) Phosphodiesterase 4 inhibition affects both the direct and indirect pathway: an electrophysiological study examining the tri-phasic response in the substantia nigra pars reticulata. Brain Structure and Function 223:2, pages 739-748.
Crossref
Crossref
Clark R. Sims, Sharda P. Singh, Shengyu Mu, Neriman Gokden, Dala Zakaria, Trung C. Nguyen & Philip R. Mayeux. (2017) Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome. Frontiers in Pharmacology 8.
Crossref
Crossref
Roberta Ricciarelli, Chiara Brullo, Jos Prickaerts, Ottavio Arancio, Carla Villa, Claudia Rebosio, Elisa Calcagno, Matilde Balbi, Britt T. J. van Hagen, Elentina K. Argyrousi, Hong Zhang, Maria Adelaide Pronzato, Olga Bruno & Ernesto Fedele. (2017) Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease. Scientific Reports 7:1.
Crossref
Crossref
Pim R. A. Heckman, Arjan Blokland & Jos Prickaerts. 2017. Phosphodiesterases: CNS Functions and Diseases. Phosphodiesterases: CNS Functions and Diseases
135
168
.
Steven J. Clapcote. 2017. Phosphodiesterases: CNS Functions and Diseases. Phosphodiesterases: CNS Functions and Diseases
103
131
.
Amy Aldrich, Megan E. Bosch, Rachel Fallet, Jessica Odvody, Maria Burkovetskaya, Kakulavarapu V. Rama Rao, Jonathan D. Cooper, Arlene V. Drack & Tammy Kielian. (2016) Efficacy of phosphodiesterase‐4 inhibitors in juvenile Batten disease (CLN3). Annals of Neurology 80:6, pages 909-923.
Crossref
Crossref
Roman Mathaes, Atanas Koulov, Susanne Joerg & Hanns-Christian Mahler. (2016) Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries. Journal of Pharmaceutical Sciences 105:8, pages 2255-2259.
Crossref
Crossref
Gary W. Hoyle, Jing Chen, Connie F. Schlueter, Yiqun Mo, David M. HumphreyJr.Jr., Greg Rawson, Joe A. Niño & Kenneth H. Carson. (2016) Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation. Toxicology and Applied Pharmacology 298, pages 9-18.
Crossref
Crossref
Tim Vanmierlo, Pim Creemers, Sven Akkerman, Marlies van Duinen, Anke Sambeth, Jochen De Vry, Tolga Uz, Arjan Blokland & Jos Prickaerts. (2016) The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses. Behavioural Brain Research 303, pages 26-33.
Crossref
Crossref
Sven Akkerman, Arjan Blokland & Jos Prickaerts. (2015) Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approach. Learning & Memory 23:1, pages 29-37.
Crossref
Crossref
Ya Miao, Ting He, Yitong Zhu, Wei Li, Beiyuan Wang & Yuan Zhong. (2015) Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats. Cellular and Molecular Neurobiology 35:8, pages 1157-1164.
Crossref
Crossref
Chia-Lang Fang, Chih-Jen Wen, Ibrahim A. Aljuffali, Calvin T. Sung, Chun-Lin Huang & Jia-You Fang. (2015) Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study. Journal of Controlled Release 213, pages 69-78.
Crossref
Crossref
Kelle M. Franklin, Sheketha R. Hauser, Amy W. Lasek, Jeanette McClintick, Zheng-Ming Ding, William J. McBride & Richard L. Bell. (2015) Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology 232:13, pages 2251-2262.
Crossref
Crossref
Satoko Kimura, Yoshiaki Ohi & Akira Haji. (2015) Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance without loss of analgesia. Life Sciences 127, pages 32-38.
Crossref
Crossref
Eva Bollen, Daniela Puzzo, Kris Rutten, Lucia Privitera, Jochen De Vry, Tim Vanmierlo, Gunter Kenis, Agostino Palmeri, Rudi D'Hooge, Detlef Balschun, Harry MW Steinbusch, Arjan Blokland & Jos Prickaerts. (2014) Improved Long-Term Memory via Enhancing cGMP-PKG Signaling Requires cAMP-PKA Signaling. Neuropsychopharmacology 39:11, pages 2497-2505.
Crossref
Crossref
Arjan Blokland, Nick van Goethem, Pim Heckman, Rudy Schreiber & Jos Prickaerts. (2014) Translational Issues with the Development of Cognition Enhancing Drugs. Frontiers in Neurology 5.
Crossref
Crossref
S. Akkerman, A. Blokland & J. Prickaerts. (2014) Mind the gap: Delayed manifestation of long-term object memory improvement by phosphodiesterase inhibitors. Neurobiology of Learning and Memory 109, pages 139-143.
Crossref
Crossref
Furuzan AkarOguz MutluIpek K. CelikyurtEmine BektasMehmet H. TanyeriGuner UlakPelin TanyeriFaruk Erden. (2014) Effects of Zaprinast and Rolipram on Olfactory and Visual Memory in the Social Transmission of Food Preference and Novel Object Recognition Tests in Mice. Drug Target Insights 8, pages DTI.S14813.
Crossref
Crossref
Pelin Tanyeri. (2014) Zaprinast and Rolipram Enhances Spatial and Emotional Memory in the Elevated Plus Maze and Passive Avoidance Tests and Diminishes Exploratory Activity in Naive Mice. Medical Science Monitor Basic Research 20, pages 105-111.
Crossref
Crossref
Peter Kraft, Tobias Schwarz, Eva Göb, Nadine Heydenreich, Marc Brede, Sven G. Meuth & Christoph Kleinschnitz. (2013) The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood–brain-barrier damage, inflammation and thrombosis. Experimental Neurology 247, pages 80-90.
Crossref
Crossref
Hao Zhang, Shao‐Bo Zhang, Qing‐Qing Zhang, Meng Liu, Xing‐Ying He, Zui Zou, Hai‐Jing Sun, Zhen‐Dong You & Xue‐Yin Shi. (2013)
Rescue of c
AMP
Response Element‐Binding Protein Signaling Reversed Spatial Memory Retention Impairments Induced by Subanesthetic Dose of Propofol
. CNS Neuroscience & Therapeutics 19:7, pages 484-493.
Crossref
Crossref
Rui‐Ting Wen, Min Zhang, Wang‐Jun Qin, Qing Liu, Wei‐Ping Wang, Andrew J. Lawrence, Han‐Ting Zhang & Jian‐Hui Liang. (2012)
The Phosphodiesterase‐4 (
PDE
4) Inhibitor Rolipram Decreases Ethanol Seeking and Consumption in Alcohol‐Preferring Fawn‐Hooded Rats
. Alcoholism: Clinical and Experimental Research 36:12, pages 2157-2167.
Crossref
Crossref
Chuang Wang, Xue-Mei Yang, Ye-Ye Zhuo, Heng Zhou, Huan-Bing Lin, Yu-Fang Cheng, Jiang-Ping Xu & Han-Ting Zhang. (2011) The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats. The International Journal of Neuropsychopharmacology 15:06, pages 749-766.
Crossref
Crossref
Mireille Lortie, Jean N. DaSilva, Miran Kenk, Stephanie Thorn, Darryl Davis, David Birnie, Rob S. B. Beanlands & Robert A. deKemp. (2011) Analysis of (R)- and (S)-[11C]rolipram Kinetics in Canine Myocardium for the Evaluation of Phosphodiesterase-4 with PET. Molecular Imaging and Biology 14:2, pages 225-236.
Crossref
Crossref
V Wiescholleck & D Manahan-Vaughan. (2012) PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis. Translational Psychiatry 2:3, pages e89-e89.
Crossref
Crossref
L. Homer, E. Launay, N. Joram, C. Jacqueline, P.-H. Jarreau, J. Caillon, T. Moyon, B. Branger, G. Potel, J. C. Roze, C. Méhats & C. Gras-LeGuen. (2012) Antenatal Phosphodiesterase 4 Inhibition Restores Postnatal Growth and Pulmonary Development in a Model of Chorioamnionitis in Rabbits. Journal of Pharmacology and Experimental Therapeutics 340:3, pages 620-628.
Crossref
Crossref
Maïte Hotte, François Dauphin, Thomas Freret, Michel Boulouard & Guenaëlle Levallet. (2012) A Biphasic and Brain-Region Selective Down-Regulation of Cyclic Adenosine Monophosphate Concentrations Supports Object Recognition in the Rat. PLoS ONE 7:2, pages e32244.
Crossref
Crossref
Wei Hu, Tina Lu, Alan Chen, Ying Huang, Rolf Hansen, L. Judson Chandler & Han-Ting Zhang. (2011) Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology 218:2, pages 331-339.
Crossref
Crossref
Kevin R. Smith, David Leonard, Jacob D. McDonald & Yohannes Tesfaigzi. (2011) Inflammation, mucous cell metaplasia, and Bcl-2 expression in response to inhaled lipopolysaccharide aerosol and effect of rolipram. Toxicology and Applied Pharmacology 253:3, pages 253-260.
Crossref
Crossref
Bora InceogluKaren WagnerNils H. SchebbChristophe MorisseauSteven L. Jinks, Arzu UluChristine HegedusTristan RoseRobert Brosnan & Bruce D. Hammock. (2011) Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP. Proceedings of the National Academy of Sciences 108:12, pages 5093-5097.
Crossref
Crossref
Haining DaiLinda MacArthurMarietta McAteeNicole HockenburyJ. Lille TidwellBrian McHughKevin MansfieldTom FinnFrank P.T. HamersBarbara S. Bregman. (2009) Activity-Based Therapies To Promote Forelimb Use after a Cervical Spinal Cord Injury. Journal of Neurotrauma 26:10, pages 1719-1732.
Crossref
Crossref
Ajaib S. Paintlia, Manjeet K. Paintlia, Inderjit Singh, Robert B. Skoff & Avtar K. Singh. (2008) Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis. Glia 57:2, pages 182-193.
Crossref
Crossref
Ajaib S. Paintlia, Manjeet K. Paintlia, Inderjit Singh & Avtar K. Singh. (2008) Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. Experimental Neurology 214:2, pages 168-180.
Crossref
Crossref
K. Rutten, J. Prickaerts, G. Schaenzle, H. Rosenbrock & A. Blokland. (2008) Sub-chronic rolipram treatment leads to a persistent improvement in long-term object memory in rats. Neurobiology of Learning and Memory 90:3, pages 569-575.
Crossref
Crossref
M.N. de Lima, J. Presti-Torres, V.A. Garcia, M.R. Guimarães, F.S. Scalco, R. Roesler & N. Schröder. (2008) Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats. Neuropharmacology 55:5, pages 788-792.
Crossref
Crossref
David R. Sprague, Masahiro Fujita, Yong Hoon Ryu, Jeih-San Liow, Victor W. Pike & Robert B. Innis. (2008) Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [11C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses. Nuclear Medicine and Biology 35:4, pages 493-500.
Crossref
Crossref
Sari S. Hannila & Marie T. Filbin. (2008) The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Experimental Neurology 209:2, pages 321-332.
Crossref
Crossref
SARI S. HANNILA & MARIE T. FILBIN. 2008. CNS Regeneration. CNS Regeneration
389
411
.
Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy & Ashley N. Martin. (2007) Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology 192:3, pages 415-424.
Crossref
Crossref
Kris Rutten, Jos Prickaerts, Martin Hendrix, F. Josef van der Staay, Ayhan Şik & Arjan Blokland. (2007) Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. European Journal of Pharmacology 558:1-3, pages 107-112.
Crossref
Crossref
S.J. Kanes, J. Tokarczyk, S.J. Siegel, W. Bilker, T. Abel & M.P. Kelly. (2007) Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience 144:1, pages 239-246.
Crossref
Crossref
Sari S. Hannila, Mustafa M. Siddiq & Marie T. Filbin. 2007. The Pharmacology of Neurogenesis and Neuroenhancement. The Pharmacology of Neurogenesis and Neuroenhancement
57
105
.
C. S. Moore, N. Earl, R. Frenette, A. Styhler, J. A. Mancini, D. W. Nicholson, A. L. O. Hebb, T. Owens & G. S. Robertson. (2006) Peripheral Phosphodiesterase 4 Inhibition Produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) Prevents Experimental Autoimmune Encephalomyelitis. Journal of Pharmacology and Experimental Therapeutics 319:1, pages 63-72.
Crossref
Crossref
Mireille Lortie, Jean DaSilva, Miran Kenk, Stephanie Thorn, Rob Beanlands & Robert deKemp. (2006) Kinetics of (R)-[11C] rolipram and (S)-[11C] rolipram In the Dog Heart: Investigation of Four Compartment Models. Kinetics of (R)-[11C] rolipram and (S)-[11C] rolipram In the Dog Heart: Investigation of Four Compartment Models.
Y. Bureau, M. Handa, Y. Zhu, F. Laliberte, C.S. Moore, S. Liu, Z. Huang, D. MacDonald, D.G. Xu & G.S. Robertson. (2006) Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline. Neuropharmacology 51:5, pages 974-985.
Crossref
Crossref
Jennifer A. Davis & Thomas J. Gould. (2005) Rolipram Attenuates MK-801-Induced Deficits in Latent Inhibition.. Behavioral Neuroscience 119:2, pages 595-602.
Crossref
Crossref
Bing Gong, Ottavio V. Vitolo, Fabrizio Trinchese, Shumin Liu, Michael Shelanski & Ottavio Arancio. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. Journal of Clinical Investigation 114:11, pages 1624-1634.
Crossref
Crossref
Bing Gong, Ottavio V. Vitolo, Fabrizio Trinchese, Shumin Liu, Michael Shelanski & Ottavio Arancio. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. Journal of Clinical Investigation 114:11, pages 1624-1634.
Crossref
Crossref
Jonathan Burns, Donald F. Weaver, Jonathan Burns & Donald F. Weaver. (2014) A Mathematical Model for Prediction of Drug Molecule Diffusion Across the Blood-Brain Barrier. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 31:4, pages 520-527.
Crossref
Crossref
Tetsuji Itoh, Miwa Tokumura & Kohji Abe. (2004) Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. European Journal of Pharmacology 498:1-3, pages 135-142.
Crossref
Crossref
Elena Nikulina, J. Lille Tidwell, Hai Ning Dai, Barbara S. Bregman & Marie T. Filbin. (2004) The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the National Academy of Sciences 101:23, pages 8786-8790.
Crossref
Crossref
Barbara E. Thompson, Benjamin D. Sachs, Kathleen M. Kantak & James A. Cherry. (2004) The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. European Journal of Neuroscience 19:9, pages 2561-2568.
Crossref
Crossref
Jie Zhu, Eilhard Mix & Bengt Winblad. (2006) The Antidepressant and Antiinflammatory Effects of Rolipram in the Central Nervous System. CNS Drug Reviews 7:4, pages 387-398.
Crossref
Crossref
Celia M Lourenco, Sylvain Houle, Alan A Wilson & Jean N DaSilva. (2001) Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats. Nuclear Medicine and Biology 28:4, pages 347-358.
Crossref
Crossref
Jean N. DaSilva, Celia M. Lourenco, Alan A. Wilson & Sylvain Houle. (2001) Syntheses of the phosphodiesterase-4 inhibitors [11C]Ro 20-1724, R-, R/S- and S-[11C]rolipram. Journal of Labelled Compounds and Radiopharmaceuticals 44:5, pages 373-384.
Crossref
Crossref
James A Cherry, Barbara E Thompson & Vanee Pho. (2001) Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1518:1-2, pages 27-35.
Crossref
Crossref
Mark A. Giembycz. (2000) Phosphodiesterase 4 Inhibitors and the Treatment of Asthma. Drugs 59:2, pages 193-212.
Crossref
Crossref
Mark A. Giembycz. 2000. High Throughput Screening for Novel Anti-Inflammatories. High Throughput Screening for Novel Anti-Inflammatories
223
253
.
Clifford M. Knapp, Melissa M. Foye, Domenic A. Ciraulo & Conan Kornetsky. (1999) The Type IV Phosphodiesterase Inhibitors, Ro 20-1724 and Rolipram, Block the Initiation of Cocaine Self-Administration. Pharmacology Biochemistry and Behavior 62:1, pages 151-158.
Crossref
Crossref
Mark Barad, Roussoudan Bourtchouladze, Danny G. Winder, Hava Golan & Eric Kandel. (1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proceedings of the National Academy of Sciences 95:25, pages 15020-15025.
Crossref
Crossref
ARMIN J. BECKER, CHRISTIAN G. STIEF, MARKUS MEYER, MICHAEL C. TRUSS, WOLF G. FORSSMANN & UDO JONAS. (1998) THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE-IV-INHIBITOR ROLIPRAM ON THE URETHERAL PERISTALSIS OF THE RABBIT IN VITRO AND IN VIVO. Journal of Urology 160:3 Part 1, pages 920-925.
Crossref
Crossref
Richard J. Heaslip & Deborah Y. Evans. (1995) Emetic, central nervous system and pulmonary activities of rolipram in the dog. European Journal of Pharmacology 286:3, pages 281-290.
Crossref
Crossref
G. D. Nordblom & C. M. Barksdale. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs
23
39
.
Roger M. Pinder & Joop H. Wieringa. (1993) Third-generation antidepressants. Medicinal Research Reviews 13:3, pages 259-325.
Crossref
Crossref
W. Krause & G. Kühne. (1992) High-performance liquid chromatographic procedure for specificity testing of radioimmunoassays: rolipram. Journal of Chromatography B: Biomedical Sciences and Applications 573:2, pages 303-308.
Crossref
Crossref
W. Krause, G. K�hne & N. Sauerbrey. (1990) Pharmacokinetics of (+)-rolipram and (?)-rolipram in healthy volunteers. European Journal of Clinical Pharmacology 38:1, pages 71-75.
Crossref
Crossref
Mark S. Kleven, William L. Woolverton & Lewis S. Seiden. (1989) Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Research 488:1-2, pages 121-125.
Crossref
Crossref